Evidence map›Paper›PMID 42626449›Full record

ArticleCureus2026

Albendazole-Induced Liver Injury Mimicking Autoimmune Hepatitis.

Aren Nersisyan, Narek Kocharyan, Lusine Mardanyan, Arman Mirumyan, Arshak Shahenyan

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aren NersisyanDepartment of Gastroenterology and Hepatology, Nairi Medical Center, Yerevan, ARM.
Narek KocharyanDepartment of Gastroenterology and Hepatology, Nairi Medical Center, Yerevan, ARM.
Lusine MardanyanDepartment of Histopathology, Davidyants Polyclinics, Yerevan, ARM.
Arman MirumyanDepartment of Gastroenterology and Hepatology, Nairi Medical Center, Yerevan, ARM.
Arshak ShahenyanDepartment of Pathophysiology, Yerevan State Medical University, Yerevan, ARM.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced liver injury is one of the leading causes of acute liver injury and may mimic other liver diseases, including idiopathic autoimmune hepatitis. Although albendazole is generally a safe antiparasitic agent, it can be associated with rare cases of clinically significant liver injury; it can even cause a mixture of both types of injuries, or a type of hepatitis that is similar to an autoimmune disease, such as positive autoantibodies and elevated IgG, making differential diagnosis more difficult. We present a case of albendazole-induced liver injury mimicking autoimmune hepatitis in a 41-year-old woman with marked hyperbilirubinemia, positive ANA, and elevated IgG levels, in whom liver biopsy and clinical follow-up played an important role in clarifying the diagnosis.

Indexed as

albendazole antihelminthicautoimmune liver diseaseautoimmune vs drug-induced liver damagedrug-induced liver injury (dili)liver damage

Identifiers

PMID42626449
PMCPMC13493095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.